The chemical, genetic and immunological basis of idiosyncratic drug–induced liver injury
Open Access
- 26 November 2015
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 34 (12) , 1310-1317
Abstract
Idiosyncratic drug reactions can be extremely severe and are not accounted for by the regular pharmacology of a drug. Thus, the mechanism of idiosyncratic drug–induced liver injury (iDILI), a phenomenon that occurs with many drugs including β-lactams, anti-tuberculosis drugs and non-steroidal anti-inflammatories, has been difficult to determine and remains a pressing issue for patients and drug companies. Evidence has shown that iDILI is multifactorial and multifaceted, which suggests that multiple cellular mechanisms may be involved. However, a common initiating event has been proposed to be the formation of reactive drug metabolites and covalently bound adducts. Although the fate of these metabolites are unclear, recent evidence has shown a possible link between iDILI and the adaptive immune system. This review highlights the role of reactive metabolites, the recent genetic innovations which have provided molecular targets for iDILI, and the current literature which suggests an immunological basis for iDILI.Keywords
This publication has 81 references indexed in Scilit:
- Acute cholestatic hepatitis caused by amoxicillin/clavulanateWorld Journal of Gastroenterology, 2013
- Limited contribution of common genetic variants to risk for liver injury due to a variety of drugsPharmacogenetics and Genomics, 2012
- Human Leukocyte Antigen (HLA)-B*57:01-Restricted Activation of Drug-Specific T cells Provides the Immunological Basis for Flucloxacillin-Induced Liver InjuryHepatology, 2012
- Characteristics of Idiosyncratic Drug‐induced Liver Injury in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2011
- Case Definition and Phenotype Standardization in Drug-Induced Liver InjuryClinical Pharmacology & Therapeutics, 2011
- Epidemiology of Idiosyncratic Drug-Induced Liver InjurySeminars in Liver Disease, 2009
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinNature Genetics, 2009
- Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicityToxicology and Applied Pharmacology, 2003
- Drug-Induced Liver DisordersDrug Safety, 2001
- Isoniazid-Associated HepatitisAmerican Review of Respiratory Disease, 1972